Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 2,039 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Not an interventional study Clear all

Conditions: Contraception
Interventions: Blood draw, ESSURE (BAY1454032), Laparoscopic tubal sterilization; Procedure · Device
Lead sponsor: Bayer; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 990 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 57
States / cities: Chandler, Arizona • Phoenix, Arizona • Tucson, Arizona + 47 more

Conditions: Drug Abuse, Nicotine Dependence
Interventions: MagPro X100 Magnetic Stimulator, Transcranial Rotating Magnetic Stimulator, Magnetom Prisma Fit 3T Scanner; Device
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Post-traumatic Stress Disorder (PTSD)
Interventions: Accelerated Resolution Therapy (ART); Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 8
States / cities: Clearwater, Florida • Holiday, Florida • Jupiter, Florida + 5 more

Conditions: Liver Transplant
Interventions: arTreg-CSB, leukapheresis, cyclophosphamide, mesna, everolimus; Biological · Procedure · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: STI, Sexually Transmitted Infection (STI), Sexually Transmitted Disease (STD)
Interventions: STIckER, Control; Behavioral · Other
Lead sponsor: Columbia University; Other
Eligibility: 14 Years to 24 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: New York, New York

Conditions: Diabetes, Breast Cancer
Interventions: Integrated Intervention for Breast Cancer Survivors with Diabetes, Attention Control; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 55 Years and older · Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Chicago, Illinois • New Hyde Park, New York • New York, New York

Conditions: Colorectal Cancer Screening, Prevention & Control
Interventions: Educational outreach; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 628 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sleep, Burnout, Work Engagement
Interventions: Heartfulness Meditation; Other
Lead sponsor: WellSpan Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: York, Pennsylvania

Conditions: Anterior Ischemic Optic Neuropathy
Interventions: Diagnostic procedures; Drug
Lead sponsor: Bayer; Industry
Eligibility: 40 Years and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2018
U.S. locations: 11
States / cities: Vista, California • Atlantis, Florida • Fort Myers, Florida + 7 more

Conditions: Adverse Outcomes Post-hospital Discharge
Interventions: Electronic delivery of enhanced discharge information to the ambulatory physician; Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 65 Years and older
Enrollment: 5,077 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Healthy
Interventions: Computer-based cognitive training; Behavioral
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Healthy, Chronic Illnesses, Multiple
Interventions: DigiKnowIt News: Teen; Behavioral
Lead sponsor: Innovation Research & Training; Other
Eligibility: 12 Years to 17 Years
Enrollment: 255 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Neuroectodermal Tumors, Primitive, Liver Neoplasms, Osteosarcoma, Other Childhood Cancers Using Cisplatin-based Regimens
Interventions: N-Acetylcysteine; Drug
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 1 Year to 21 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ischemic Stroke
Interventions: Active Sphenopalatine Ganglion (SPG) Stimulation, Sham Sphenopalatine Ganglion (SPG) Stimulation; Device
Lead sponsor: BrainsGate; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 1,078 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 7
States / cities: Sarasota, Florida • Winfield, Illinois • Greensboro, North Carolina + 3 more

Conditions: PCOS (Polycystic Ovary Syndrome), Obese Adolescents, Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight Adolescents, Irregular Menstrual Cycle, Irregular Menstrual Cycles, Hirsutism, Hyperandrogenism
Interventions: Beef+; Other
Lead sponsor: Texas A&M University; Other
Eligibility: 11 Years to 17 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: College Station, Texas

Conditions: Diabetes, Hyperglycemia
Interventions: Best Practice Advisory; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: Not listed
Enrollment: 7,232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Resilience, HIV-1-infection, Stress, Psychological
Interventions: RISE+, Stress Reduction Control; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 50 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Fecal Immunochemical Test, Colorectal Cancer Screening
Interventions: Implementation Intention Guide; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 1,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 5
States / cities: Lebanon, New Hampshire • Lyme, New Hampshire • White River Junction, Vermont

Conditions: Angioplasty Patients
Interventions: Intervention Group; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Tobacco Use
Interventions: Newly developed warnings with images at 30% size, FDA proposed text-only warnings at 30% size; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 1,029 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Pregnancy, Induction of Labor
Interventions: Electric breast pump for nipple stimulation, induction of labor; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Respiratory Disease, Acute Respiratory Infection, Respiratory Infection, Upper Respiratory Infection
Interventions: Online Tutorial, Webinars, Booster Sessions, Feedback Reports, Parent Survey; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Months to 10 Years
Enrollment: 2,728 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 20
States / cities: Paragould, Arkansas • Eureka, California • Durango, Colorado + 16 more

Conditions: Sedentary Lifestyle, Obesity
Interventions: Financial incentives for increasing physical exercise; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Dyspepsia
Interventions: Alimetry, tVNS, Gastroduodenal Manometry; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization

Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

Prospective Cohort Study of Accelerated Resolution Therapy (ART) for Treatment of Military Psychological Trauma

Liver Transplantation With Tregs at MGH

A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study

Integrated Intervention for Breast Cancer Survivors With Diabetes

Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders

Effect of Four-Week Wellness Program on Work Engagement Burnout and Sleep in a Healthcare Organization (WEBS)

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Improving Posthospital Medication Management of Older Adults Through Health IT

Blood Neurotrophic Factors in Adults

Website for Adolescents About Pediatric Clinical Trials

NAC to Prevent Cisplatin-induced Hearing Loss

Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window

Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)

Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia

Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV

Implementation Intention Planning Guide for FIT Colon Cancer Screening

A Randomized Trial: Changing Behavior in Post-Angioplasty Patients

Little Cigar and Cigarillo Warnings Among US Adults Who Use LCCs

Is Nipple Stimulation Effective for Inducing Labor and Acceptable to Patients, Nurses, and Providers?

Dialogue Around Respiratory Illness Treatment

Financial Incentives for Increasing Exercise

High Resolution Gastric Mapping and Gastroduodenal Manometry